Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Research Article, Androl Gynecol Curr Res Vol: 3 Issue: 1
Discovery of a New Anti Androgen Compound
| Mustafa Pehlivan* |
| School of Life and Medical Sciences, University of Hertfordshire, College Lane, Hatfield, Hertfordshire AL 10 9AB, UK |
| Corresponding author : Mustafa Pehlivan School of Life and Medical Sciences, University of Hertfordshire, College Lane, Hatfield, Hertfordshire AL 10 9AB, UK Tel: 447758414188; E-mail: Mustafa.pehlivan@yahoo.com.uk.tr |
| Received: November 17, 2014 Accepted: March 13, 2015 Published: March 20, 2015 |
| Citation: Pehlivan M (2015) Discovery of a New Anti Androgen Compound. Androl Gynecol: Curr Res 3:1. doi:10.4172/2327-4360.1000134 |
Abstract
Discovery of a New Anti Androgen Compound
Androgen receptor inhibitors reduce or eliminate symptoms of prostate cancer by inhibiting Androgen receptors. The main advantage of this new compound is that it does not block any other receptors except androgen, and therefore it is very specific. Also another advantage of it in terms of its mechanism of inhibition is that its inhibition efficacy is about 90%, and therefore it would be a very efficient anti-cancer drug for prostate cancer and related diseases. Also when compared to other anti-Androgen drugs, this drug has a different and better enzalutamide activity.
